TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from 4DMedical Ltd ( (AU:4DX) ).
4DMedical Ltd announced the issuance of unquoted securities, including 679,085 performance rights and 2,711,738 options, as part of an employee incentive scheme. This move is likely to impact the company’s operational strategy by aligning employee interests with company performance, potentially enhancing its market position and stakeholder value.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on developing innovative imaging solutions. The company is known for its advanced respiratory imaging technology, which aims to enhance diagnostics and treatment in healthcare.
Average Trading Volume: 7,196,699
Technical Sentiment Signal: Buy
Current Market Cap: A$1.19B
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.